��������

Anna Batarina is currently the Director at Intergalactic Therapeutics. Anna has over fifteen years of experience in the financial and international tax services industry. Prior to their current position, they served as the VP for Strategic Development at Braeburn from September 2016 to December 2016. From June 2015 to September 2015, they were a Consultant on the strategy team for The Global Fund to Fight AIDS, Tuberculosis and Malaria. Anna Batarina began their professional career in 2004 as the SVP, Head of Capital Markets and Investor Relations for Uralkali. In this role, they were responsible for overseeing the company's capital markets activities and investor relations strategy. Anna then spent a year as an Associate for A1 / Alfa Eco before joining Ernst & Young in 2000. At Ernst & Young, Anna Batarina quickly rose through the ranks, becoming a Senior Consultant in the Financial and International Tax Services division within three years. Throughout their career, Anna Batarina has demonstrated their ability to develop and implement effective strategies that drive business growth. Her experience and expertise have made their a valuable asset to Intergalactic Therapeutics.

Anna Batarina has a Master of Science from The Johns Hopkins University in Individual Genomics and Health, a Graduate Certificate in Global Health from Yale University, and a Master of Arts in Global Affairs with a focus in Global Health from Yale University. Anna also has a Master of Science in Clinical Psychology from Lomonosov Moscow State University and a Bachelor of Science in Finance from the Finance University under the Government of the Russian Federation.